| abstract |
The invention relates to the field of biological medicine, and discloses a skin care product rich in ligustilide, which is characterized by comprising 0.02-8% of ligustilide by mass percent. Ligustilide can effectively increase the secretion of type I collagen (COI-1), inhibit the expression of inflammatory cytokine IL-1 beta in cells, reduce the activation of NF-kB signal channel, increase the secretion of collagen and inhibit the inflammatory reaction of cells by regulating human fibroblasts (HDF cells), thereby achieving the effects of resisting aging and removing acnes. |